Neurogenic Bladder clinical trials
22 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury
- Oxybutynin for Post-surgical Bladder Pain and Urgency
- Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria
- Tibial Nerve Stimulation for Pediatric Spina Bifida Neurogenic Bladder
- Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
- Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
- Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life
- Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- Intravesical LGG VS Saline Bladder Wash RCT
- Consumer Evaluation of an Investigational Intermittent Catheter
- Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
- NXT Post-Market Clinical Follow-up
- Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use
- Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
- Device for Bladder Control for Men With SCI
- A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections
- Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD
- Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections
- Empowerment Program to Reduce Treatment of Asymptomatic Bacteriuria in Veterans With Spinal Cord Injury
- Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing
- Use of Wearables Following Cystectomy- Part II
- Early BOTOX After Spinal Cord Injury
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Neurogenic Bladder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.